Navigation Links
Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program
Date:4/27/2009

Program to Launch During RESOLVE's National Infertility Awareness Week(R), April 25 - May 2 Across the Country

PARSIPPANY, N.J., April 27 /PRNewswire/ -- Ferring Pharmaceuticals, which offers the broadest portfolio of fertility treatments in the U.S., has partnered with leading patient advocate organization, RESOLVE: The National Infertility Association, to launch the RESOLVE Nurse Liaison Program during National Infertility Awareness Week(R) (NIAW), April 25-May 2. The program was developed to create a network of nurses from every Society for Assisted Reproductive Technology (SART) member infertility center in the United States to serve as RESOLVE ambassadors in their medical practice. Since nurses play a crucial role in the patient care process, the program was designed to arm them with relevant information about treatment options and valuable educational materials for infertility patients.

Nurses who enroll in the RESOLVE Nurse Liaison Program will receive e-communication on a regular basis with up-to-date patient education materials and other available resources. In addition, RESOLVE will periodically ask for feedback from nurses on the current state of patient education in infertility and gaps that they see in patient's knowledge. As a member of this valuable program, nurses will be prominently featured on RESOLVE's Web site and have the opportunity to contribute articles and speak at RESOLVE events.

"RESOLVE is proud to collaborate with Ferring Pharmaceuticals especially during National Infertility Awareness Week(R). Our goal is to spread information about infertility and its treatments to those fighting the disease of infertility," said Barbara Collura, RESOLVE's executive director. "We are thrilled to be partnering with a leader in the field of infertility who can help RESOLVE provide vital information to the nurses who are on the front lines of the patient care journey."

"Ferring is pleased to be working with RESOLVE to give nurses the resources they need to enhance the patient care journey," said Olivier Delannoy, vice president, Infertility Business Unit at Ferring. "As a leader in providing patients with access to affordable and user-friendly treatment options, Ferring remains committed to supporting the reproductive community with the tools they need to help simplify the patient treatment process."

Nurses who are interested in becoming a member of the RESOLVE Nurse Liaison Program can visit www.resolve.org/nurseprogram. Upon receipt of the registration form, RESOLVE will send a program welcome packet that outlines the details of the program.

About Ferring Pharmaceuticals

Ferring Pharmaceuticals, part of the Ferring Group, a privately owned, international pharmaceutical company, manufactures and markets the largest family of fertility treatments in the U.S. The Company markets MENOPUR, BRAVELLE, REPRONEX(R) (menotropins for injection, USP), NOVAREL(R) (chorionic gonadotropin for injection, USP) and ENDOMETRIN(R) (progesterone) Vaginal Insert in the U.S. to infertility specialists and their patients. Ferring also offers the Q-CAP(TM), the first and only needle-free reconstitution device, for use with its fertility treatments.

Ferring's line of orthopaedic and urology products includes EUFLEXXA(R) (1% sodium hyaluronic acid) and PROSED(R) DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate). Other products include: ACTHREL(R) (corticorelin ovine triflutate for injection), DESMOPRESSIN and DEGARELIX for injection.

The Ferring Group specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/ gynecology, infertility and orthopaedics. For more information, call 888-337-7464 or visit www.ferringusa.com or www.ferringfertility.com.

About RESOLVE: The National Infertility Association

Founded in 1974, RESOLVE: The National Infertility Association, headquartered in McLean, VA, is the oldest and largest consumer-based, nonprofit group that provides education, advocacy and compassionate support for those struggling with infertility in the United States. Each year, RESOLVE and its nationwide network of affiliates handle more than 1.5 million contacts from people seeking information and help. For more information, visit the RESOLVE website at www.resolve.org.


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Educating referring clinicians about advanced imaging leads to drop in imaging exams
2. Frost & Sullivan Accolade for Ferring Pharmaceuticals
3. Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
4. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
5. Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System
6. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
7. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
8. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
9. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
10. Medimetriks Pharmaceuticals Launches Two New Prescription Brands
11. PUR Water Filtration Systems Can Reduce Trace Levels of Pharmaceuticals Found in Some U.S. Tap Water
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
(Date:10/4/2017)... 2017  According to the Centers for Disease Control and Prevention (CDC), ... PhysicianOne Urgent Care is helping communities across Massachusetts , ... by offering no-cost* flu shots through the end of the month. ... insurance regulations. ... get a flu shot is by the end of October, according to ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
Breaking Medicine Technology: